- Companies
- Company K Partners
Company K Partners Valuation Multiples
Company K Partners is valued at $51M as of November 2026, a 2.8x revenue multiple. In the last fiscal year, Company K Partners revenue was $16M and Company K Partners EBITDA was $8M.
Company K Partners Overview
About Company K Partners
Company K Partners Ltd is a South Korea based venture capital company involved in partnering with entrepreneurs to deliver market-transforming value in new industrial frontiers. The portfolio of investments of the company include Equity investment in the sectors of Internet, Mobile, Software, Healthcare and Project Investment.
Founded
2006
HQ
Employees
N/A
Website
Sectors
Financials (Last FY)
EV
$44M
Valuation Multiples
Start free trialCompany K Partners Financials
Company K Partners reported last fiscal year revenue of $16M and EBITDA of $8M.
In the same fiscal year, Company K Partners generated $14M in gross profit, $8M in EBITDA, and $5M in net income.
Company K Partners P&L
In the most recent fiscal year, Company K Partners reported revenue of $16M and EBITDA of $8M.
Company K Partners is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 48%, and net margin of 34%.
Financial data powered by Morningstar, Inc.
Company K Partners Stock Performance
Company K Partners has current market cap of $51M, and enterprise value of $44M.
Market Cap Evolution
Company K Partners' stock price is $3.24.
Company K Partners share price decreased by 12.5% in the last 30 days, and by 19.4% in the last year.
Company K Partners has an EPS (earnings per share) of $0.34.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $44M | $51M | -0.1% | -12.5% | -29.3% | -19.4% | $0.34 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCompany K Partners Valuation Multiples
Company K Partners trades at 2.8x EV/Revenue multiple, and 5.8x EV/EBITDA.
Company K Partners Financial Valuation Multiples
As of November 9, 2026, Company K Partners has market cap of $51M and EV of $44M.
Company K Partners has a P/E ratio of 9.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Company K Partners Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Company K Partners Margins & Growth Rates
In the most recent fiscal year, Company K Partners reported gross margin of 85%, EBITDA margin of 48%, and net margin of 34%.
Company K Partners Margins
Company K Partners Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Company K Partners Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Company K Partners Competitors
Company K Partners competitors include Elron Ventures, Stonebridge Ventures, GBK Beteiligungen, Acorn Capital Investment Fund, Quest for Growth, Atinum Investment, Agronomics, LB Investment, Xlife Sciences and Trendlines Group.
Most Company K Partners public comparables operate across PE & VC.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | $12M | - | - | 2.0x | - | |||
| $19M | $10M | 1.3x | - | 2.4x | - | |||
| $471K | - | 80.6x | - | - | - | |||
| $7M | - | 6.6x | - | - | - | |||
| ($2M) | - | (31.1x) | - | - | - | |||
| $52M | $24M | 0.6x | - | 1.4x | - | |||
| ($16M) | ($46M) | (3.5x) | - | (1.2x) | - | |||
| $20M | $8M | 2.2x | - | 5.5x | - | |||
This data is available for Pro users. Sign up to see all Company K Partners competitors and their valuation data. Start Free Trial | ||||||||
Investments by Company K Partners
Company K Partners has invested in 115 companies to date.
Latest investment by Company K Partners was on October 14th 2026. Company K Partners invested in RX in their $7M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by Company K Partners
| Description | RX Inc. is a nuclear engineering company based in Daejeon, South Korea, working on Small Modular Reactor (SMR) design and licensing. It was founded in 2023 by engineers from KAERI, the Korea Atomic Energy Research Institute, and describes itself as the only SMR startup directly founded by that institute. The company follows a fabless model, creating value through reactor design and intellectual property across design, analysis, testing and licensing. It also develops agentic AI tools meant to speed the preparation of design and licensing documents. An earlier product line covered on-site analysis of material properties for environmental, energy and inspection uses. Work is supported by national R&D programmes. | Turing is a South Korea-based AI platform dedicated to mathematics education. The service employs artificial intelligence to deliver personalized tutoring and learning experiences for students. It focuses on interactive problem-solving and adaptive curricula tailored to individual proficiency levels. Available through teamturing.com, the platform supports K-12 math instruction with real-time feedback and progress tracking. | KaliVir Immunotherapeutics is a clinical-stage biotechnology company developing oncolytic viral immunotherapies for solid tumors. The company's pipeline combines proprietary viral platforms with licensed technology from the University of Pittsburgh to create candidates that harness viral replication and immune activation against cancer. | StepLab is a microsatellite developer that creates satellite platforms and space mechanisms for deployment, operations, and various commercial or research missions. | |
| HQ Country | |||||
| HQ City | Daejeon | Seoul | Pittsburgh, PA | Daejeon | |
| Deal Date | 14 Oct 2026 | 1 Sep 2026 | 19 Aug 2026 | 5 Aug 2026 | |
| Round | Seed | Series B | Series A | Series A | |
| Raised | $7M | $5M | $14M | $8M | |
| Investors | Smilegate Investment; Korea Development Bank; Kiwoom Investment; Company K Partners | Korea Development Bank; Company K Partners; Kingo Investment Partners; Kolon Investment | Nextrans; SV Investment; Company K Partners; QUAD Investment Management; Flexus Partners | Korea Credit Guarantee Fund; Mirae Asset Venture Investment; D·CAMP; Company K Partners; Kolon Investment; SL Investment; IBK Venture Investment | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Company K Partners investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Company K Partners
| When was Company K Partners founded? | Company K Partners was founded in 2006. |
| Where is Company K Partners headquartered? | Company K Partners is headquartered in South Korea. |
| Is Company K Partners publicly listed? | Yes, Company K Partners is a public company listed on Korea Exchange. |
| What is the stock symbol of Company K Partners? | Company K Partners trades under 307930 ticker. |
| When did Company K Partners go public? | Company K Partners went public in 2019. |
| Who are competitors of Company K Partners? | Company K Partners main competitors include Elron Ventures, Stonebridge Ventures, GBK Beteiligungen, Acorn Capital Investment Fund, Quest for Growth, Atinum Investment, Agronomics, LB Investment, Xlife Sciences, Trendlines Group. |
| What is the current market cap of Company K Partners? | Company K Partners' current market cap is $51M. |
| What is the current revenue of Company K Partners? | Company K Partners' last fiscal year revenue is $16M. |
| What is the current EV/Revenue multiple of Company K Partners? | Current revenue multiple of Company K Partners is 2.8x. |
| Is Company K Partners profitable? | No, Company K Partners is not profitable. |
| How many companies Company K Partners has acquired to date? | Company K Partners hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Company K Partners has invested to date? | As of November 2026, Company K Partners has invested in 115 companies. |
| What was the last Company K Partners investment? | On 14th October 2026 Company K Partners invested in RX, participating in a $7M Seed round, alongside Smilegate Investment, Korea Development Bank, and Kiwoom Investment. |
| In what companies Company K Partners invested in? | Company K Partners invested in XCENA, Upstage, WIRobotics, CHAI, Mobilint, HyperAccel, Banksalad, Rainist, Curocell, Prazer Therapeutics, Rapport Labs, OncXerna Therapeutics, RIDI, Kmong, Balaan, J2H Biotech, Jaranda, Catch Table, Mediquitous, KoBioLabs, and 95 other companies. |
See public comps similar to Company K Partners
Lists including Company K Partners
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




